Nalmefene: all 35 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- TH104 for the Treatment of Pruritus in Primary Biliary CholangitisNot yet recruitingNCT06733519Phase 2
- NAlmefene Versus Placebo in Addition to Treatment As Usual on Craving in Behavioural AddictionsRecruitingNCT05540288Phase 3
- Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mgCompletedNCT06719986Phase 1Results posted
- Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing RegimensCompletedNCT05219669Phase 1Results posted
- Pharmacodynamic Evaluation of Intranasal NalmefeneCompletedNCT04828005Phase 1Results posted
- Pharmacokinetic Evaluation of Intranasal NalmefeneCompletedNCT04759768Phase 1Results posted
- St. PETERsburg Pain and Alcohol Intervention With Naltrexone and NalmefeneCompletedNCT03278886Phase 1/2Results posted
- Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative HyperalgesiaCompletedNCT03096730Not applicableResults posted
- A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male SubjectsCompletedNCT02679469Phase 1Results posted
- JKB-121 for the Treatment of Nonalcoholic SteatohepatitisCompletedNCT02442687Phase 2Results posted
- A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol DependenceCompletedNCT02382276Phase 3Results posted
- A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)CompletedNCT02364947Phase 3Results posted
- Efficacy of Nalmefene in Patients With Alcohol DependenceCompletedNCT00812461Phase 3Results posted
- Safety and Efficacy of Nalmefene in Patients With Alcohol DependenceCompletedNCT00811941Phase 3Results posted
- Efficacy of Nalmefene in Patients With Alcohol DependenceCompletedNCT00811720Phase 3Results posted
- Pharmacokinetic (PK) Evaluation of Nalmefene FormulationsCompletedNCT07543276Phase 1
- Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid OverdoseWithdrawnNCT06408714Phase 3
- An Evaluation of The Absolute Bioavailability of TH104CompletedNCT06198686Phase 1
- Clinical Outcomes From NalmefeneWithdrawnNCT05808881Phase 4
- Reversal of Opioid-induced Respiratory Depression With Opioid AntagonistsTerminatedNCT05338632Phase 1
- Effect of Nalmefene on the Quality of Resuscitation in Patients Under General AnesthesiaCompletedNCT04713358Phase 4
- Patient Driven Recovery With Nalmefene and CoachingCompletedNCT03279562Phase 1
- Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy VolunteersCompletedNCT03129347Phase 1
- Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control SubjectsCompletedNCT03034408Phase 2
- Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label StudyStatus unknownNCT02934919Phase 2
- Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.WithdrawnNCT02824354Phase 3
- Nalmefene in Alcohol Dependence and Borderline Personality DisorderStatus unknownNCT02752503Not applicable
- Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene VariationCompletedNCT02639273Phase 1
- Single-dose of Nalmefene to Modulate Neural Alcohol Cue ReactivityTerminatedNCT02372318Early Phase 1
- Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed UseCompletedNCT02197598Phase 4
- Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary CareTerminatedNCT02195817Phase 4
- Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy SubjectsCompletedNCT01934166Phase 1
- Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated PruritusCompletedNCT00838708Phase 2
- Nalmefene Smoking Cessation StudyCompletedNCT00202696Phase 2
- Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological GamblingCompletedNCT00132119Phase 2/3